Table 1 Clinical and demographic characteristics of the samples

Demographic characteristics

 Age (years), mean ± SD

62.89 ± 10.38

62.97 ± 9.96

t = −0.164

0.870*

 Gender (Males/females)

948/539

464/236

χ2 = 1.335

0.248^#

 Nourishment status (Well/general/poor)

351/1042/94

171/486/40

χ2 = 0.626

0.731^#

Clinical characteristics

 History of splenectomy (None/yes)

954/533

461/239

χ2 = 0.603

0.437^#

 Comorbidities (None/cardiovascular/digestive/others)

712/167/328/280

360/75/146/119

χ2 = 2.526

0.471^#

 Clinical classification (Splenomegaly/Ascites)

176/1311

97/603

χ2 = 1.780

0.182^#

 Course of disease (years), median (IQR)

5.00 (3.00–8.00)

5.00 (2.25–8.00)

z = −0.375

0.707^$

 Frequencies of ascites (times), median (IQR)

6.00 (4.00–9.00)

6.00 (3.00–9.00)

z = −1.144

0.253^$

 Survival outcome (Death/survival)

123/1364

52/648

χ2 = 0.460

0.498^#

Laboratory test indices

 TBil (μmol/L), median (IQR)

15.59 (11.43–20.80)

15.5 0 (11.40–21.00)

z = 0.229

0.819$

 DBil (μmol/L), median (IQR)

4.70 (3.20–6.87)

4.70 (3.20–6.95)

z = −0.118

0.906^$

 ALT (µ/L), median (IQR)

26.35 (19.00–38.14)

26.00 (18.09–38.99)

z = −0.100

0.920^$

 AST (µ/L), median (IQR)

36.2 0 (28.20–48.00)

36.00 (28.00–48.04)

z = −0.255

0.799^$

 ALP (µ/L), median (IQR)

94.00 (73.00–125.00)

92.00 (73.00–124.00)

z = −0.427

0.669^$

 ALB (g/L), median (IQR)

40.90 (36.00–44.20)

40.78 (36.31–44.10)

z = −0.038

0.969^$

 HBsAg (Negative/positive)

1219/268

578/122

χ2 = 0.115

0.735^#

 AFP (Negative/positive)

1452/35

680/20

χ2 = 0.492

0.483^#